Display options
Cite
Shealy CN. A review of dehydroepiandrosterone (DHEA). Integr Physiol Behav Sci. 1995;30(4):308-13doi: 10.1007/BF02691603.
Shealy, C. N. (1995). A review of dehydroepiandrosterone (DHEA). Integrative physiological and behavioral science : the official journal of the Pavlovian Society, 30(4), 308-13. https://doi.org/10.1007/BF02691603
Shealy, C N. "A review of dehydroepiandrosterone (DHEA)." Integrative physiological and behavioral science : the official journal of the Pavlovian Society vol. 30,4 (1995): 308-13. doi: https://doi.org/10.1007/BF02691603
Shealy CN. A review of dehydroepiandrosterone (DHEA). Integr Physiol Behav Sci. 1995 Sep-Dec;30(4):308-13. doi: 10.1007/BF02691603. PMID: 8788227.
Copy Download .nbib Format: NLM
Share it on

Integr Physiol Behav Sci. 1995 Sep-Dec;30(4):308-13. doi: 10.1007/BF02691603.

A review of dehydroepiandrosterone (DHEA).

Integrative physiological and behavioral science : the official journal of the Pavlovian Society

C N Shealy

Affiliations

  1. Shealy Institute, Springfield, MO 65803, USA.

PMID: 8788227 DOI: 10.1007/BF02691603

Abstract

Dehydroepiandrosterone (DHEA) is quantitatively the most abundant hormone in humans and mammals, with a wide variety of physiological effects, including major regulatory effects upon the immune system. Two of the most striking aspects of DHEA are a steady decline in DHEA with age and a significant deficiency in DHEA in patients with several major diseases, including cancer, atherosclerosis, and Alzheimer's disease. The hormone is secreted in a non-sulfated (DHEA) and sulfated form (DHEA-S). The two are apparently interchangeable, and it appears likely that its physiological effects are achieved by derivative molecules that have yet to be identified.

References

  1. J Gerontol. 1993 Jul;48(4):M134-9 - PubMed
  2. J Clin Endocrinol Metab. 1993 Jul;77(1):80-5 - PubMed
  3. FASEB J. 1992 Sep;6(12):3073-5 - PubMed
  4. J Cell Biochem Suppl. 1993;17G:73-9 - PubMed
  5. Mol Cell Neurosci. 1994 Apr;5(2):176-81 - PubMed
  6. Ann N Y Acad Sci. 1995 Dec 29;774:217-31 - PubMed
  7. Am J Physiol. 1991 Mar;260(3 Pt 1):E486-91 - PubMed
  8. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  9. Neoplasma. 1992;39(1):39-42 - PubMed
  10. J Clin Invest. 1988 Aug;82(2):712-20 - PubMed
  11. Am J Med Sci. 1993 Feb;305(2):79-83 - PubMed
  12. Am J Physiol. 1992 Aug;263(2 Pt 1):E210-3 - PubMed
  13. Gerontology. 1986;32(1):43-51 - PubMed
  14. J Infect Dis. 1992 Mar;165(3):413-8 - PubMed
  15. Eur J Immunol. 1990 Apr;20(4):793-802 - PubMed
  16. J Infect Dis. 1991 Nov;164(5):864-8 - PubMed
  17. J Psychosom Res. 1993 May;37(4):345-54 - PubMed
  18. Geburtshilfe Frauenheilkd. 1994 Jun;54(6):321-31 - PubMed
  19. Ann N Y Acad Sci. 1991;621:363-72 - PubMed
  20. J Clin Endocrinol Metab. 1994 Jun;78(6):1360-7 - PubMed
  21. J Clin Endocrinol Metab. 1984 Sep;59(3):551-5 - PubMed
  22. Gerontology. 1986;32(6):335-9 - PubMed
  23. Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):219-21 - PubMed
  24. Eur J Appl Physiol Occup Physiol. 1990;61(1-2):149-58 - PubMed
  25. Haematologica. 1994 Mar-Apr;79(2):141-7 - PubMed
  26. Pharmacol Biochem Behav. 1994 Mar;47(3):437-41 - PubMed
  27. Neoplasma. 1994;41(2):101-3 - PubMed
  28. Am J Med Sci. 1993 Nov;306(5):320-4 - PubMed
  29. J Behav Med. 1992 Aug;15(4):327-41 - PubMed
  30. Rev Clin Esp. 1992 May;190(8):398-402 - PubMed
  31. Exp Clin Endocrinol. 1992;99(2):68-70 - PubMed

Substances

MeSH terms

Publication Types